MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Net Income
-$689K
EPS
-$0.65
Unit: Thousand (K) dollars
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2025-06-30
2024-09-30
2024-06-30
General and administrative
657
754
2,074
Total operating expenses
657
754
2,074
Loss from operations
-657
-754
-2,074
Other expense
-32
-9
-
Other nonoperating expense
-
-
19
Interest income
0
-
-
Other expense, net
-32
-9
-19
Net loss
-689
-763
-2,093
Basic EPS
-0.65
-0.83
-2.29
Diluted EPS
-0.65
-0.83
-2.29
Basic Average Shares
1,065,000
914,000
914,000
Diluted Average Shares
1,065,000
914,000
914,000
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Net loss
-$689K
(67.08%↑ Y/Y)
Loss from operations
-$657K
(68.32%↑ Y/Y)
Other expense, net
-$32K
(-68.42%↓ Y/Y)
Total operating
expenses
$657K
(-68.32%↓ Y/Y)
Other expense
-$32K
General and
administrative
$657K
(-68.32%↓ Y/Y)
Buy us a coffee
TITAN PHARMACEUTICALS INC (TTNP)
TITAN PHARMACEUTICALS INC (TTNP)